Bumper Offer - Urjas oil Just @ Rs. 1
Telsartan 20 Tablet (14) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Heart Failure, High BP. Other than this, Telsartan 20 Tablet (14) has some other therapeutic uses, which have been discussed ahead.
The right dosage of Telsartan 20 Tablet (14) depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Telsartan 20 Tablet (14) also has some side effects, the most common being Dizziness, Nausea or vomiting, Back Pain. Apart from the aforementioned side effects, Telsartan 20 Tablet (14) can also lead to other problems, which have been listed below. These side effects of Telsartan 20 Tablet (14) are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Telsartan 20 Tablet (14) is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Telsartan 20 Tablet (14) related warnings talks about Telsartan 20 Tablet (14)'s effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Angioedema, Hyperkalemia, Drug Allergy must refrain from the use of Telsartan 20 Tablet (14) since this can cause severe adverse effects.
Besides this, Telsartan 20 Tablet (14) may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Telsartan 20 Tablet (14) is considered not safe while driving, and is not addictive.
Telsartan 20 Tablet (14) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Telsartan 20 Tablet (14) is used -
Severe
Mild
Common
Is the use of Telsartan 20 Tablet (14) safe for pregnant women?
Telsartan has many dangerous side effects in pregnant women. If you are pregnant, do not consume Telsartan without medical advice.
Is the use of Telsartan 20 Tablet (14) safe during breastfeeding?
Breastfeeding women can take Telsartan as it bears very minor side effects for them.
What is the effect of Telsartan 20 Tablet (14) on the Kidneys?
Telsartan does not damage the kidneys.
What is the effect of Telsartan 20 Tablet (14) on the Liver?
Telsartan may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Telsartan 20 Tablet (14) on the Heart?
Side effects of Telsartan rarely affect the heart.
Telsartan 20 Tablet (14) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telsartan 20 Tablet (14) unless your doctor advises you to do so -
Is this Telsartan 20 Tablet (14) habit forming or addictive?
Forming a habit of Telsartan 20 Tablet (14) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Telsartan 20 Tablet (14) can make you feel drowsy.
Is it safe?
Telsartan 20 Tablet (14) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Telsartan 20 Tablet (14) in mental disorders is not effective.
Interaction between Food and Telsartan 20 Tablet (14)
Eating certain foods may increase the time it takes Telsartan 20 Tablet (14) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Telsartan 20 Tablet (14)
Consumption of alcohol and Telsartan 20 Tablet (14) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
